openPR Logo
Press release

Anticoagulant Rodenticides Market Is Projected To Reach A Valuation Of US$ 1.4 Bn By 2032

06-16-2022 10:46 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

The global Anticoagulant rodenticides Market is estimated at US$ 720.4 Mn in 2022 and is projected to reach a valuation of US$ 1.4 Bn by 2032, expanding at a CAGR of 3.3% through the forecast period of 2022-2032.

Anticoagulant rodenticides find their application in a multitude of industries including agriculture, metropolitan centres, and residences, as well as pest control firms and warehouses. Over the projected period, the market for anticoagulant rodenticides is predicted to rise due to growing demand for rodenticides to reduce the rodent population. During the projected period, increased demand for rodent control, the prevalence of rodent-related illnesses, an increase in rat population, and the availability of natural rodent control solutions are expected to drive market growth globally.

To remain 'ahead' of your competitors, request for a sample - https://www.factmr.com/connectus/sample?flag=S&rep_id=7249

The report offers actionable and valuable market insights of Anticoagulant Rodenticides. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Anticoagulant Rodenticides across various industries and regions.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Anticoagulant Rodenticides. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Anticoagulant Rodenticides

This newly published and insightful report sheds light on Market Insights of Anticoagulant Rodenticides, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Anticoagulant Rodenticides.

Key Companies Profiled
• BASF SE
• Bayer
• Syngenta
• UPL
• Liphatech Inc.
• JT Eaton
• Neogen Corporation
• Pelgar International
• Senestech Inc.
• Bell Laboratories
• Impex Europa
• Rentokil Initial Plc
• Terminix
• Ecolab

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=S&rep_id=7249

Key Segments Covered in Anticoagulant Rodenticides Industry Survey
Product Type Outlook
• 1st Generation Anticoagulants
• 2nd Generation Anticoagulants

Form Outlook
• Pellets
• Blocks
• Powders & Sprays

Application Outlook
• Agriculture
• Pest Control Companies
• Warehouses
• Urban Centers
• Household
• Others

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/7249

Which type of Anticoagulant Rodenticides is set to Garner High Share?
Second-generation anticoagulant rodenticides are longer to break down than first-generation anticoagulant rodenticides, and therefore represent a larger risk of secondary poisoning in non-target animals. Because of their decreased toxicity compared to 2nd generation anticoagulant rodenticides, demand for 1st generation anticoagulant rodenticides is predicted to rise throughout the forecast period.

In Australia, three active ingredients of first-generation anticoagulant rodenticides have been approved for usage. The Australian Pesticides and Veterinary Medicines Authority has approved and accepted diphacinone, coumatetralyl, and warfarin for use near industrial, agricultural, commercial, and residential structures. Coumatetralyl is permitted for use on crops, however only in covered bait stations as part of a comprehensive rodent control programme.

Explore Fact.MR's Coverage on the Chemicals and Materials Domain:

Bio-succinic Acid Market - https://www.factmr.com/report/5405/biosuccinic-acid-market

Surge Suppression IC Market - https://www.factmr.com/report/surge-suppression-ic-market

Liquid Propellants Market - https://www.factmr.com/report/Liquid-Propellants-Market

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

About US

Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we'll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anticoagulant Rodenticides Market Is Projected To Reach A Valuation Of US$ 1.4 Bn By 2032 here

News-ID: 2655178 • Views:

More Releases from Fact.MR

Muscle Stimulators Market is Valued USD 1.43 billion in 2025 | Key players include Actinium Pharmaceuticals, Inc., Alpha Tau Medical, Bayer AG, Fusion Pharmaceuticals, IBA Group, IBA Radiopharma Solutions, Lantheus Medical Imaging
10-01-2025 | Health & Medicine
Fact.MR
Muscle Stimulators Market is Valued USD 1.43 billion in 2025 | Key players inclu …
The global muscle stimulators market is set for significant expansion, with its valuation expected to increase from USD 1.43 billion in 2025 to USD 2.92 billion by 2035. This growth corresponds to a compound annual growth rate (CAGR) of 7.4% over the forecast period from 2025 to 2035. The market's robust trajectory is driven by rising awareness of health and fitness, technological advancements in rehabilitation devices, and the increasing prevalence
Sleeping Aids Market to extend USD 131.3 Billion by 2035 | Abecca Healthcare, Becton, Dickinson and Company, Betterlifehealthcare Ltd., Cadwell Industries, Inc., Compumedics Ltd., GlaxoSmithKline, Inc., Hill-Rom Holdings
10-01-2025 | Health & Medicine
Fact.MR
Sleeping Aids Market to extend USD 131.3 Billion by 2035 | Abecca Healthcare, Be …
Fact.MR today unveiled its latest report on the Sleeping Aids Market, forecasting robust growth amid escalating sleep disorders, heightened stress levels, and a global push for restorative wellness solutions. Valued at USD 78.3 billion in 2025, the global market is projected to expand at a compound annual growth rate (CAGR) of 5.3%, reaching USD 131.3 billion by 2035. This trajectory reflects the market's pivotal role in addressing widespread insomnia, sleep
Marketing Automation Market Will Hit USD 26.68 Billion by 2034 | Adobe; Hubspot; Salesforce; SAS; Oracle; Acoustic; Act-on Software; SendinBlue
Marketing Automation Market Will Hit USD 26.68 Billion by 2034 | Adobe; Hubspot; …
The global marketing automation market is experiencing robust growth, valued at USD 6.83 billion in 2024 and forecasted to reach USD 26.68 billion by 2034. This expansion reflects a compound annual growth rate (CAGR) of 14.6% over the forecast period from 2024 to 2034. The surge is primarily driven by the escalating demand for targeted advertising, enhanced user retention, and data-backed strategies in digital marketing channels. As internet penetration and
Integrated Workplace Management System Market to Reach USD 10.6 Billion by 2034, Driven by Digital Transformation and Hybrid Work Trends
Integrated Workplace Management System Market to Reach USD 10.6 Billion by 2034, …
The global Integrated Workplace Management System (IWMS) market is experiencing significant growth, with projections indicating an increase from approximately USD 4 billion in 2024 to USD 10.6 billion by 2034, reflecting a compound annual growth rate (CAGR) of 10.2% over the period from 2025 to 2034. This expansion is attributed to the rising demand for automation in facility management, the adoption of digital workplace solutions, and the need for efficient

All 5 Releases


More Releases for Anticoagulant

Peptide Anticoagulant Drugs Market Massive Growth opportunity Ahead
Peptide Anticoagulant Drugs market Size, Status, and Forecast for the 2025-2034. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Peptide Anticoagulant Drugs Market including drivers, restraints, historical and current trends, regulatory scenarios, and technological advancements. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply
Anticoagulant Rodenticides Market Is Expanding So Quickly
USD Analytics Market recently introduced Global Anticoagulant Rodenticides Market study with 65+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2024-2032). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are BASF, Bayer, Syngenta, Rentokil, LiphaTech, JT Eaton, Bell Laboratories,
Anticoagulant Reversal Drugs Market In-Depth Analysis 2029
Fairfield Market Research offers a complete understanding of the Global Anticoagulant Reversal Drugs Market in its latest research report. The report includes an unbiased analysis of the market dynamics. The report covers growth prospects, market development potential, product profitability, supply and demand curves and predictions, and government policies. The report has been put together using reliable tools to assess the primary and secondary data. The data is represented in the
Anticoagulant Treatment Market 2021 | Detailed Report
The Anticoagulant Treatment market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Anticoagulant Treatment report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4988667 The Anticoagulant Treatment research report also provides
Anticoagulants Market To See Record Break Revenue $43.42 Million By 2025 | Vitam …
Anticoagulants are medicinal substances that reduce the coagulation of blood and prolong the clotting time. Anticoagulant drugs achieve their effects by suppressing the synthesis or function of various clotting factors that exist in the blood. The global anticoagulants market is anticipated to show significant market growth during the forecast period, owing to increase in prevalence of ischemic heart disease and venous thromboembolism (VTE) and awareness of novel oral anticoagulants (NOACs).
Anticoagulant Drugs Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Anticoagulant Drugs market. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/241687/global-anticoagulant-drugs-market Global Anticoagulant Drugs Market: Forecast by Type / Application / Region Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time. According to this study, over the next five years the Anticoagulant Drugs